Wayne, Pa. (March 29, 2018) – McBee health care consulting and executive leadership will present an informative session focusing on creating a formal drug diversion compliance program to instill misuse prevention during the HFMA Hudson Valley NY 2018 Annual Institute. The conference will take place in Tarrytown, NY on April 5.
Jeff Clayton, Vice President – Principal, and Mykel Banks, Manager, will present the session “Compliance: Drug Diversion and Misuse Prevention” primarily focusing on the many steps and key components of creating a formal comprehensive drug diversion program. In addition, Clayton and Banks will outline the necessary collaboration efforts of each department to develop and implement a successful program. Attendees will receive the tools to begin their process of developing policies and procedures, implementing performance metrics and providing the outline for the overall direction of a program.
Jeff Clayton has over 30 years of consulting experience in revenue cycle management. He leads McBee’s Acute Consulting Practice and has extensive experience working with the OPPS reimbursement model and identifying significant revenue opportunities for McBee’s client base. Mykel Banks has more than ten years consulting experience in comprehensive compliance oversight and maintenance and has a wide-range of experience in ensuring facilities full corporate awareness, understanding and compliance with all pertinent laws and regulations.
McBee is the nation’s premier independent health care services and consulting firm that delivers financial, operational, and clinical consulting services exclusively to healthcare providers across the continuum of care. For more than 40 years, McBee has designed services to ensure the success of clients by improving clinical, operational, and revenue cycle performance. Corporate headquarters is in Wayne, Pennsylvania. Additional offices are located in New York, New York, Columbia, Maryland, Richmond, Virginia, and Charlotte, North Carolina. Visit us at McBeeAssociates.com or call
800.767.6203. Follow us on Twitter and LinkedIn.